Fig. 6 | Scientific Reports

Fig. 6

From: Counteracting methicillin resistant Staphylococcus aureus through novel Citral-Azithromycin combination

Fig. 6

Assessment of nucleic acid content release from MRSA clinical isolate MB-1137. The graph depicts the release of intracellular components following treatment with (a) citral alone, (b) azithromycin alone, and (c) the combination of citral with azithromycin. Measurements were taken at minimum inhibitory concentration (MIC), 2×MIC, and 4×MIC. Data are presented as mean values with standard deviations, highlighting the effects of each treatment on cellular integrity.

Back to article page